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Evaluation (APACHE II) scores of the patients in 
their ICU were 16.4±7.5 for 360 patients receiving 
standard care, 15.7±7.5 for 339 patients receiving 
SOD, and 16.4±7.7 for 314 patients receiving SDD, 
with observed inclusion rates of 88%, 91%, and 
87% for the three groups, respectively. Their re-
mark that “correction factors were determined af-
terward” is incorrect, since all variables on case-
record forms — which were used throughout the 
study — were included as covariates.
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Behavioral Management for Anorexia Nervosa
To the Editor: In their article on behavioral 
management for anorexia nervosa (Jan. 29 issue),1 
Attia and Walsh state that the Maudsley Method 
(in which parents take control of refeeding of 
their child) is the preferred treatment for children 
and adolescents, but  I wonder why they do not 
recommend it for the 23-year-old woman described 
in the vignette. For decades, the conventional wis-
dom was that a “toxic” parent–child relationship 
caused this disorder. Parents were told to “back 
off” and were barred from the treatment team.2 
This cruel and inaccurate bias has lingered in psy-
chiatry. Attia and Walsh note that weight restora-
tion is accepted as being paramount for treatment. 
They also note that inpatient treatment lasts for 
18 days, on average, and is associated with a re-
lapse rate of 50% in the first year after hospital-
ization. When parents are empowered to refeed 
their child, they do so for as long as it takes, 
which is usually many months.3 We await clinical 
trials using the Maudsley Method in young adults.
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To the Editor: We agree with the authors that 
structured multidisciplinary behavioral programs 
that integrate nutritional and psychological treat-
ments are the most promising approaches in the 
management of anorexia nervosa. However, their 
nutritional-support program raises concern. Cer-
tainly, priority is given to providing adequate 
calories,1 and institutions may opt for different 
protocols. However, in our experience, patients fre-
quently report considerable difficulties in begin-
ning therapy with such large quantities of solid 
food (1800 kcal per day); such quantities are prob-
ably unrealistic and may be harmful. Patients with 
anorexia nervosa are at high risk for the refeed-
ing syndrome.2-4 When  similar high-calorie nutri-
tional regimens are enforced, the risk of compli-
cations is very high.1-4 To avoid complications, 
both current guidelines and expert panels suggest 
10 kcal per kilogram of body weight per day for 
nutritional support during the first 3 days, re-
gardless of the route of administration.3,4 A cau-
tious increase (by 400 to 500 kcal every 3 days) can 
then be proposed to obtain a positive energy bal-
ance.1,3 Weight and electrolyte levels should be 
checked daily to rule out excessive water retention 
and correct any impairment.
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The Authors Reply: In response to Scolnick: we 
did not recommend a prime role for the family of 
the 23-year-old patient described in our review be-
cause the limited data available suggest that the 
Maudsley family-based approach is not particularly 
effective in this age group.1 However, we concur 
that it is important to involve the family to the 
degree that family members are available to help. 
Controlled trials would be useful to obtain em-
pirical data regarding the usefulness of family 
members’ taking a major role in the refeeding of 
persons with anorexia nervosa in this age group.
Cereda et al. express concern about the refeed-
ing syndrome. In our review, we recommend care-
ful medical monitoring during initial refeeding. 
The guidelines of the National Institute for Health 
and Clinical Excellence2 suggest starting nutri-
tional support at 10 kcal per kilogram per day in 
order to avoid the refeeding syndrome. However, 
this recommendation appears to be overly cautious 
for most persons with anorexia nervosa, since it 
is intended to assist in the care of all malnour-
ished persons, including those who may have un-
derlying cardiovascular compromise or who may 
have suddenly interrupted intake for 15 days 
or more.3 The American Psychiatric Association 
guidelines for the treatment of patients with eat-
ing disorders suggest starting refeeding at 30 to 
40 kcal per kilogram per day,4 as do Golden and 
Meyer in their review of refeeding in anorexia ner-
vosa.5 In our experience, persons with anorexia 
nervosa may report a reluctance to eat, but they 
will commonly tolerate being offered 1800 kcal 
in solid food, generally consuming this diet suc-
cessfully within a few days after hospital admis-
sion and showing physiological tolerance of this 
caloric load as well as additional increases needed 
to achieve consistent weight gain in the weeks that 
follow. 
As mentioned in the review by Mehanna et al.,3 
vitamin supplementation should be started im-
mediately on refeeding, and supplements of po-
tassium, phosphate, calcium, and magnesium 
should be considered. Lower levels of initial ca-
loric intake may be appropriate for persons with 
weights that are unusually low (body-mass index 
[the weight in kilograms divided by the square of 
the height in meters], ≤14), who have undergone 
particularly abrupt weight loss before presentation, 
or who are known to have ingested negligible 
calories in the previous 2 weeks.
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More on Eculizumab for Congenital Atypical  
Hemolytic–Uremic Syndrome
To the Editor: In their letter to the editor about 
eculizumab for congenital atypical hemolytic–ure-
mic syndrome, Gruppo and Rother (Jan. 29 issue)1 
report that they used eculizumab in an 18-month-
old boy at an initial dose of 300 mg and a main-
tenance dose of 600 mg — half and two thirds of 
the adult doses (600 mg and 900 mg), respective-
ly.2 These doses may be relatively high, because 
this patient weighed only 12 kg, and the body-
surface area is approximately 0.5 m2, which may 
be less than one third of the adult area. The ap-
propriate dose and the pharmacokinetics of this 
drug in children or in patients with renal failure 
have not yet been studied. Therefore, especially in 
young children, eculizumab should be used cau-
tiously because of the high risk of meningococcal 
infection2; the lowest effective dose of eculizumab 
should be determined according to the plasma drug 
level. Because plasma eculizumab levels of more 
than 35 μg per milliliter are required to block 
complement activation in adults,2 the initial dose 
should be calculated on the basis of body-surface 
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